Creative Biolabs moves beyond simple differential gene expression (DGE) to deliver a clear, actionable roadmap to the most impactful therapeutic targets. Our service is fundamentally engineered to address the core problem of aging: the systemic, dynamic dysregulation of gene regulatory networks (GRNs). By focusing on network-centric analysis rather than isolated genes, we identify master switches that can stabilize the entire aging system, ensuring maximum therapeutic leverage and minimizing resource waste on low-impact targets.
An extended healthspan requires maintaining cellular homeostasis, which aging destabilizes through network dysregulation within GRNs. The entire transcriptome captured by bulk RNA sequencing provides the essential, high-dimensionality blueprint of this state. We overcome inter-study noise with robust QC. The most advanced approach uses integrated single-cell precision (scRNA-seq) to validate cell-type-specific markers across bulk RNA-seq cohorts, identifying key orchestrators—the highly connected regulatory nodes—that can redirect aging trajectories toward longevity.
We use co-expression network analysis to pinpoint highly connected hub genes (key nodes) that orchestrate entire aging GRNs. Targeting these "master switches" offers superior therapeutic impact.
You receive a detailed hypothesis and mapping of disrupted negative feedback loops, providing a rational intervention strategy to restore cellular stability and redirect the aging trajectory.
We integrate your bulk RNA-seq with publicly available single-cell RNA-seq to ensure identified signatures are specific to the most relevant cell populations, dramatically increasing predictive power.
We employ rigorous QC and normalization protocols to correct for experimental variance and batch effects, guaranteeing the cleanest, most reliable longevity signals.
Contact Creative Biolabs today to discuss how our service can transform your research from a list of genes into a roadmap for lifespan extension.
Our proprietary, five-stage process is optimized for identifying longevity-associated GRNs, ensuring clear, reproducible steps suitable for visualization.
Creative Biolabs is uniquely equipped to handle the complexities of aging biology, delivering unparalleled accuracy and translational value. Our focus on systems biology ensures that your investment yields the most impactful, high-value therapeutic leads.
Key Advantages:
PhD-level experts provide deep scientific interpretation of complex GRNs and subtle shifts in core processes like RNA splicing, transforming raw data into actionable drug discovery intelligence.
We implement robust QC and normalization methods to mitigate batch effects and inter-study noise, guaranteeing clean, reliable data necessary for target validation.
We leverage public scRNA-seq data to confirm that targets are active and critical within the specific cell type driving the pathology, providing superior prognostic power over bulk analysis.
Our pipeline is engineered to identify the few master regulators (key nodes) that yield the greatest therapeutic impact, accelerating your pipeline by prioritizing high-confidence leads.
Experience the Creative Biolabs Advantage - Get a Quote Today to Secure Your High-Value Targets
A1: Our co-expression network approach identifies hub genes that control entire regulatory modules. These hub genes offer a much higher therapeutic impact because they represent the master switches for the aging process, ensuring you target the cause, not just the symptom.
A2: Absolutely. Our service is designed to mitigate noise using rigorous batch-effect correction and normalization protocols. This capability is one of our core advantages, guaranteeing that the longevity signals we extract are clean and reliable, regardless of initial sample variability.
A3: We leverage vast, publicly available scRNA-seq datasets to identify cell-type-specific markers. We then project these signatures onto your bulk data to refine your targets, ensuring relevance to the most critical cell populations in your study.
To ensure your longevity discovery transitions seamlessly into therapeutic development, Creative Biolabs offers several complementary services:
Creative Biolabs assesses engineered gene circuit performance in cancer cells using quantification of circuit-induced cell death, fluorescent reporter, and apoptosis assays for specificity and selectivity.
Learn More →Creative Biolabs offers world-leading single-cell lineage tracing solutions. Our platform pioneers multimodal single-cell technologies, integrating DNA/mRNA/epigenetics to analyze complex, heterogeneous diseases like tumors.
Learn More →Creative Biolabs is dedicated to accelerating your journey from transcriptomics data to high-impact anti-aging therapies. Our bulk RNA sequencing based longevity gene identification service provides the precision and predictive power necessary to transform your research from a list of genes into a definitive roadmap for lifespan extension. Ready to find your next therapeutic breakthrough? We encourage you to reach out to our expert team today.